6 Experts ideas: the profitable global market in Pharma company

1
Why Invest in Pharma Franchise in India
2

• With the Indian pharmaceutical sector doing so
  well investor interest has naturally picked up.
  Today Indian pharma franchisees are attracting
  big international player who are willing to
  invest their top dollar, hoping to cash in on the
  Indian boom. Investment has been flowing in for
  big players as well as smaller pharma franchisees
  in India.
• Large local market India is a popular
  destination for goods because of its large market
  and this extends to pharmaceutical products as
  well. There is a high demand locally that has
  been driving the local markets. Experts predict
  that by 2020 India will be among the top six
  global markets in terms of size.

3
Growing Global Market Share

• While most people are focused on the massive
  Indian market, it is its global reach that is now
  of interest to the international investors. India
  is soon becoming one of the most important
  suppliers of medicines in the world. The proof
  lies in the figures.
• In terms of volume, it is the largest supplier of
  generic medicines in the world.
• More than 80 per cent of the antiretroviral drugs
  used for AIDS treatment come from India.
• The UN-backed Medicines Patent Pool has tied up
  with Indian pharma companies to supply generic
  anti-AIDS medicines to 112 developing countries.
• According to some estimates the Indian pharma
  industry is expected to grow by 15annually in
  2015-20, compared to the 5 globally!

4
Excellent Talent Pool

• For an investor the market figures are not
  everything. The bigger question is the
  sustainability of this growth. That is possible
  only if the figures are backed by expertise and
  this is where India wins over many other
  countries. India has a large talent pool in the
  form of scientists and engineers, who are crucial
  in setting up laboratories and pharma units.

5
Growing biotechnology sector

• The growth of pharma franchise company in
  India is backed by an equally rapidly growing
  biotechnology sector. Biopharma is the largest
  sub-sector, contributing 62 of the total
  revenue. Estimates put the growth of the
  bioinformatics and bio-industry at 30 annually.
• Government back-up A major reason for investing
  in the India pharma sector is the Central
  governments backing to the industry. The
  government has, through a number of policies,
  shown its commitment to the industry. With the
  clearing of 100 FDI, the government is now busy
  wooing investors. In short, this is the perfect
  time to invest in the sector.

6
ROI

• The heightened interest in this sector is because
  of the excellent return on investment that any
  investor can expect. The Indian pharma industry
  already has a well established presence with
  aggressive marketing and a solid back-up in RD.
  It also has an established market and a global
  reputation. This means excellent returns on
  investment just what an investor is looking
  for!

7
Rigorous control

• Unlike countries with sketchy inspection regime,
  the Indian authorities have strict rules
  regarding pharma industry output. The
  certificates that a creditable company carries
  include ISO, WHO, Good Manufacturing Products
  certification, Drug Controller General of India
  approval and FSSAI licensing.

8
www.fitwelpharma.com
106,Scarlet Gateway,Corporate Road,Opp.Rivera
Antilia,Prahlad Nagar,Ahmedabad-380015Gujarat,
India
Phone [phone]Cell 91 9033028080,
8469228080Fax [phone]